Literature DB >> 12622093

Severe heart failure in a young multiple sclerosis patient.

Jaystone Gbadamosi, Alexander Münchau, Cornelius Weiller, Hansjörg Schäfer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12622093     DOI： 10.1007/s00415-003-0961-z

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  3 in total

1.  Mitoxantrone in worsening secondary progressive multiple sclerosis: A prospective, open-label study.

Authors:  Bhupendra O Khatri; Mary Wroblewski; John Kramer; Mary Dukic; Arleen Poplar; A J Anderson
Journal:  Curr Ther Res Clin Exp       Date:  2006-01

Review 2.  US FDA-approved disease-modifying treatments for multiple sclerosis: review of adverse effect profiles.

Authors:  Steven L Galetta; Clyde Markowitz
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 3.  Requirement for safety monitoring for approved multiple sclerosis therapies: an overview.

Authors:  P S Rommer; U K Zettl; B Kieseier; H-P Hartung; T Menge; E Frohman; B M Greenberg; B Hemmer; O Stüve
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.